Anti-CR1 [To5]

Cat. #151360

Anti-CR1 [To5]

Cat. #: 151360

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-5 days

Target: Complement Receptor Type 1 (CR1, CD35)

Class: Monoclonal

Application: FACS ; IHC ; IF ; WB

Reactivity: Human

Host: Mouse


This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.


Inventor: Jacqueline Cordell

Institute: University of Oxford

Tool Details
Target Details

Tool Details


  • Name: Anti-CR1 [To5]
  • Clone: To5
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Reactivity: Human
  • Host: Mouse
  • Application: FACS ; IHC ; IF ; WB
  • Description: To5 may be used in studies of immune complex mediated glomerulopathies.
  • Immunogen: C3b receptor-enriched precipitates from tonsil cell membranes
  • Isotype: IgG1
  • Myeloma used: P3/NS1/1-Ag4.1

Target Details

  • Target: Complement Receptor Type 1 (CR1, CD35)
  • Target background: CR1 is found on many leucocytes and binds C3b and C4b.


  • Application: FACS ; IHC ; IF ; WB


  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Shipping at 4° C


  • Kremlitzka et al. 2013. Int Immunol. 25(1):25-33. PMID: 22962438.
  • Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients.
  • Gerdes et al. 1982. Immunology. 45(4):645-53. PMID: 7068171.
  • Human complement (C3b) receptors defined by a mouse monoclonal antibody.
  • Fearon et al. 1980. J Exp Med. 152(1):20-30. PMID: 6967510.
  • Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte.
  • Gerdes et al. 1980. Immunology. 39(1):75-84. PMID: 6991397.
  • Xenoantiserum to human C3 receptors: its preparation and effect on the C3b and C3d receptors of tonsil cells and the C3b receptors of erythrocytes and neutrophils.